Mechanisms of Drug Release in Nanotherapeutic Delivery Systems
The DOI matches its Crossref record; 493 of the 493 references it cites were found in a registry or an index.
Abstract
ADVERTISEMENT RETURN TO ISSUEPREVReviewNEXTMechanisms of Drug Release in Nanotherapeutic Delivery SystemsPamela T. Wong and Seok Ki Choi*View Author Information Michigan Nanotechnology Institute for Medicine and Biological Sciences, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109, United States*E-mail: [email protected]. Tel.: (734) 647-0052. Fax: (734) 936-2990.Cite this: Chem. Rev. 2015, 115, 9, 3388–3432Publication Date (Web):April 27, 2015Publication History Received22 August 2014Published online27 April 2015Published inissue 13 May 2015https://pubs.acs.org/doi/10.1021/cr5004634https://doi.org/10.1021/cr5004634review-articleACS PublicationsCopyright © 2015 American Chemical SocietyRequest reuse permissionsArticle Views14486Altmetric-Citations396LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Antineoplastic agents,Drug release,Molecules,Organic compounds,Peptides and proteins Get e-Alerts
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some authors evaluated the encapsulation efficiency of volatile hydrophilic compounds by Gas Chromatography, since, as a result of drug-polymeric micelle interactions, a decrease of the amount of free volatile compounds in bulk water was found [114].”
From Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions (2021) · cites this paper as [114]
Citations
Cites
1 retracted
Gui, R., Wan, A., Liu, X.-F., & Jin, H. (2014) · Chemical Communications · doi:10.1039/c3cc47981a · Cited by 52
RetractedDaniel, M.-C., & Astruc, D. (2004) · Chemical Reviews · doi:10.1021/cr030698+ · Cited by 12,446
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Laurent, S., Forge, D., Port, M., Roch, A., Robic, C., Vander Elst, L., & Muller, R. N. (2008) · Chemical Reviews · doi:10.1021/cr068445e · Cited by 6,852
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
Gupta, A. K., & Gupta, M. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.10.012 · Cited by 6,771
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Renal clearance of quantum dots
Soo Choi, H., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Itty Ipe, B., Bawendi, M. G., & Frangioni, J. V. (2007) · Nature Biotechnology · doi:10.1038/nbt1340 · Cited by 4,476
Tasis, D., Tagmatarchis, N., Bianco, A., & Prato, M. (2006) · Chemical Reviews · doi:10.1021/cr050569o · Cited by 4,273
Mammen, M., Choi, S.-K., & Whitesides, G. M. (1998) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19981102)37:20<2754::aid-anie2754>3.0.co;2-3 · Cited by 4,110
Self-citation
Research works printed but not linked: 47
- Majoros I. J., 2009, Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol., 1, 502
- Fischer M., 1999, Angew. Chem., Int. Ed., 38, 884, 10.1002/(sici)1521-3773(19990401)38:7<884::aid-anie884>3.0.co;2-k · DOI · Paper page
- Maeda H., 1989, Crit. Rev. Ther. Drug Carrier Syst., 6, 193
- Raha S., 2010, Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol., 3, 269
- Bhaskar V., 2003, Cancer Res., 63, 6387
- Hong S., 2007, Chem. Biol. (Oxford, U. K.), 14, 107
- Choi Y., 2005, Chem. Biol. (Oxford, U. K.), 12, 35
- Yellepeddi V. K., 2009, Anticancer Res., 29, 2933
- Maturo J., 1988, Biochem. Pharmacol. (Amsterdam, Neth.), 37, 3755
- de Groot F. M. H., 2002, Mol. Cancer Ther., 1, 901
- Bosnjakovic A., 2011, Nanomedicine (N. Y., NY, U. S.), 7, 284
- Levy G. A., 2006, Hepatology (Hoboken, NJ, U. S.), 43, 581
- Mahajan S. D., 2012, Methods in Enzymology, 509
- Salvi A., 1997, Drug Metab. Dispos., 25, 395
- Sanghani S. P., 2003, Clin. Cancer Res., 9, 4983
- Yoon K. J. P., 2003, Mol. Cancer Ther., 2, 1171
- Tougou K., 1998, Drug Metab. Dispos., 26, 355
- Barnes K. R., 2004, Chem. Biol. (Oxford, U. K.), 11, 557
- DeFeo-Jones D., 2000, Nat. Med. (N. Y., NY, U. S.), 6, 1248
- Wong B. K., 2001, Drug Metab. Dispos., 29, 313
- Hervio L. S., 2000, Chem. Biol. (Oxford, U. K.), 7, 443
- Silver D. A., 1997, Clin. Cancer Res., 3, 81
- Felsen C. N., 2014, Am. J. Physiol.: Lung Cell. Mol. Physiol., 306, L764
- Butler P. J., 1967, Biochem. J., 103, 78b
- Schmalfeldt B., 2001, Clin. Cancer Res., 7, 2396
- Incorvaia L., 2007, Anticancer Res., 27, 1519
- Trail P. A., 1992, Cancer Res., 52, 5693
- Hinman L. M., 1993, Cancer Res., 53, 3336
- Mahmud N. P., 1998, Anti-Cancer Drug Des., 13, 655
- Hunter F. W., 2012, Biochem. Pharmacol. (Amsterdam, Neth.), 83, 574
- van Haaften R. I. M., 2001, Biochem. Pharmacol. (Amsterdam, Neth.), 61, 715
- Rodrigues M. L., 1995, Cancer Res., 55, 63
- Rodrigues M. L., 1995, Chem. Biol. (Oxford, U. K.), 2, 223
- Goard M., 2005, Chem. Biol. (Oxford, U. K.), 12, 685
- Chourasia M. K., 2003, J. Pharm. Pharm. Sci., 6, 33
- Berchane N. S., 2007, Int. J. Pharm. (Amsterdam, Neth.), 337, 118
- Zhang M., 2011, Int. J. Nanomed., 6, 2337
- Kommareddy S., 2007, Nanomedicine (N. Y., NY, U. S.), 3, 32
- Mitran R.-A., 2014, Cent. Eur. J. Chem., 12, 1
- Wu C., 2011, Int. J. Pharm. (Amsterdam, Neth.), 403, 162
- Nelson J. L., 2002, Cancer Res., 62, 7280
- Li C., 1998, Cancer Res., 58, 2404
- Seymour L. W., 2002, J. Clin. Oncol., 20, 1668, 10.1200/jco.2002.20.6.1668 · doi:10.1200/jco.2002.20.6.1668 · Paper page
- Vasey P. A., 1999, Clin. Cancer Res., 5, 83
- Yokoyama M., 1991, Cancer Res., 51, 3229
- Wosikowski K., 2003, Clin. Cancer Res., 9, 1917
- Yurkovetskiy A., 2010, Cancer Res., 70
Cited by
Items 201–300 of 512
Plasma Synthesis of Carbon-Based Nanocarriers for Linker-Free Immobilization of Bioactive Cargo
Santos, M., Michael, P. L., Filipe, E. C., Chan, A., Hung, J., Tan, R. P., Lee, B. S. L., Huynh, M., Hawkins, C. L., Waterhouse, A., et al. (2018) · ACS Applied Nano Materials · doi:10.1021/acsanm.7b00086 · Cited by 33
Controlled Multi‐functionalization Facilitates Targeted Delivery of Nanoparticles to Cancer Cells
Hudlikar, M. S., Li, X., Gagarinov, I. A., Kolishetti, N., Wolfert, M. A., & Boons, G. (2015) · Chemistry - A European Journal · doi:10.1002/chem.201503999 · Cited by 36
Gao, Y., & Dong, C. (2017) · Polymer Chemistry · doi:10.1039/c6py01929c · Cited by 32
Driver, T. G., & Zhu, H. (2022) · Synthesis · doi:10.1055/a-1792-6579 · Cited by 32
Wang, Y., Shen, W., Shi, X., Fu, F., Fan, Y., Shen, W., Cao, Y., Zhang, Q., & Qi, R. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700276 · Cited by 32
Fluorescent Inorganic‐Organic Hybrid Nanoparticles
Neumeier, B. L., Khorenko, M., Alves, F., Goldmann, O., Napp, J., Schepers, U., Reichardt, H. M., & Feldmann, C. (2018) · ChemNanoMat · doi:10.1002/cnma.201800310 · Cited by 35
Green Synthesized Nanoparticle Based Drug Delivery: Recent Trends and Future Prospects
Kaushik, A., Singh, R. K., & Tyagi, P. K. (2023) · Precision Nanomedicine · doi:10.33218/001c.89165 · Cited by 39
“Additionally, several studies and reviews in this field emphasize the rational planning of various molecules and highlight the significance of researching various drug release mechanisms [64].”
BackgroundNanotherapeutic Heterogeneity: Sources, Effects, and Solutions
Morlà‐Folch, J., Ranzenigo, A., Fayad, Z. A., & Teunissen, A. J. P. (2023) · Small · doi:10.1002/smll.202307502 · Cited by 35
Peptide-Functionalized Hydrogel Cubes for Active Tumor Cell Targeting
Xue, B., Kozlovskaya, V., Sherwani, M. A., Ratnayaka, S. H., Habib, S., Anderson, T., Manuvakhova, M., Klampfer, L., Yusuf, N., & Kharlampieva, E. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.8b01088 · Cited by 31
Li, Z., Liu, T., Long, J., Wu, Y., Yan, B., Ma, P., & Cao, Y. (2018) · Chinese Chemical Letters · doi:10.1016/j.cclet.2018.12.011 · Cited by 31
Xu, C., Gao, F., Wu, J., Niu, S., Li, F., Jin, L., Shi, Q., & Du, L. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s213518 · Cited by 31
“Congeneric hybridization/incorporation of functional organic groups into the skeleton is a potential strategy to fabricate the MONs, which achieve tumor microenvironment-triggered biodegradation.(17) The direct incorporation of disulfide bonds into the framework has been proved as an effective strategy because it can…”
BackgroundTokarczyk, K., & Jachimska, B. (2018) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2018.10.080 · Cited by 31
Yang, C., Shi, Z., Feng, C., Li, R., Luo, S., Li, X., & Ruan, L. (2020) · Macromolecular Bioscience · doi:10.1002/mabi.202000034 · Cited by 30
pH Responsive Doxorubicin Delivery by Fluorous Polymers for Cancer Treatment
Wallat, J. D., Harrison, J. K., & Pokorski, J. K. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b01046 · Cited by 32
Mauri, E., Rossetti, A., Mozetic, P., Schiavon, C., Sacchetti, A., Rainer, A., & Rossi, F. (2019) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.11.002 · Cited by 30
Tomita, S., Ishihara, S., & Kurita, R. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b18118 · Cited by 30
Singh, H., Kim, S. J., Kang, D. H., Kim, H. R., Sharma, A. K., Kim, W., Kang, C., & Kim, J. S. (2018) · Chemical Communications · doi:10.1039/c8cc05175e · Cited by 29
Chai, S., Kan, S., Sun, R., Zhou, R., Sun, Y., Chen, W., & Yu, B. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s181681 · Cited by 29
Gangopadhyay, M., Mengji, R., Paul, A., Venkatesh, Y., Vangala, V., Jana, A., & Singh, N. D. P. (2017) · Chemical Communications · doi:10.1039/c7cc03241b · Cited by 28
Yang, W., & Zhao, X. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00467 · Cited by 28
Designing dapsone polymer conjugates for controlled drug delivery
Rojo, L., Fernández‐Gutiérrez, M., Deb, S., Stevens, M. M., & Román, J. S. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.08.047 · Cited by 28
“18 collagenase, prostate specific membrane antigen, plasmin and others) [26].”
BackgroundUltrasmall gold nanosatellite-bearing transformable hybrid nanoparticles for deep tumor penetration
Son, S., Deepagan, V. G., Shin, S., Ko, H., Min, J., Um, W., Jeon, J., Kwon, S., Lee, E. S., Suh, M., et al. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.08.019 · Cited by 28
A Redox Stimulation-Activated Amphiphile for Enhanced Photodynamic Therapy
Xue, Y., Tian, J. H., Liu, Z., Chen, J., Wu, M., Shen, Y., & Zhang, W. (2019) · Biomacromolecules · doi:10.1021/acs.biomac.9b00581 · Cited by 28
Dual acid-responsive supramolecular nanoparticles as new anticancer drug delivery systems
Wang, C., Chen, X., Yao, X., Chen, L., & Chen, X. (2015) · Biomaterials Science · doi:10.1039/c5bm00235d · Cited by 27
González‐Méndez, I., Aguayo‐Ortiz, R., Sorroza-Martínez, K., Solano, J. D., Porcu, P., Rivera, E., & Domı́nguez, L. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115510 · Cited by 27
Todea, A., Dreavă, D. M., Benea, I. C., Bîtcan, I., Péter, F., & Boeriu, C. G. (2021) · Processes · doi:10.3390/pr9040646 · Cited by 27
Braatz, D., Dimde, M., Ma, G., Zhong, Y., Tully, M., Grötzinger, C., Zhang, Y., Mavroskoufis, A., Schirner, M., Zhong, Z., et al. (2021) · Biomacromolecules · doi:10.1021/acs.biomac.1c00333 · Cited by 28
Rahimi, R., Solimannejad, M., & Soleimannejad, M. (2022) · New Journal of Chemistry · doi:10.1039/d2nj02050e · Cited by 28
Zeng, L., Jiang, L., Li, J., Huang, L. F., Chen, Y., Yu, N., Wang, L., Huang, K., Peng, J., & Han, G. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202218341 · Cited by 27
Martin, A. R., Ronco, C., Demange, L., & Benhida, R. (2016) · MedChemComm · doi:10.1039/c6md00432f · Cited by 30
Plasmonic nanocarrier grid-enhanced Raman sensor for studies of anticancer drug delivery
Kurzątkowska, K., Santiago, T., & Hepel, M. (2017) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2017.01.049 · Cited by 27
“The use of free nanoparticles (NPs) as the carriers of therapeutic molecules has extensively been explored with the aim of improving the drug efficacy and to reduce side effects (Aires et al. 2016; Latorre et al. 2014; Lim et al. 2013; Wong and Choi 2015).”
BackgroundMethodInfluentialSaini, B., Singh, R. R., Nayak, D., & Mukherjee, T. K. (2020) · ACS Applied Nano Materials · doi:10.1021/acsanm.0c00995 · Cited by 27
Smart chemistry for traceless release of anticancer therapeutics
Prange, C. J., Hu, X., & Tang, L. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122353 · Cited by 26
Photoactivation Strategies for Therapeutic Release in Nanodelivery Systems
Choi, S. K. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000117 · Cited by 27
Self-citationEmadi, R., Amiri, Z., Moghadam, F. M., Raoufi, S., Moradi, M. Z., Asadi, S., Cho, W. C., Park, J. H., Voosough, A., Farani, M. R., et al. (2026) · RSC Advances · doi:10.1039/d5ra07117h · Cited by 25
Lou, J., Zhang, X., & Best, M. D. (2018) · Chemistry - A European Journal · doi:10.1002/chem.201803389 · Cited by 25
Food-based Polymers for Encapsulation and Delivery of Bioactive Compounds
Ekrami, M., Ekrami, A., Moghaddam, R. H., Ahranjani, P. J., & Emam‐Djomeh, Z. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839168048-00488 · Cited by 25
Hybrid Nanoparticles as Drug Carriers for Controlled Chemotherapy of Cancer
Li, M., Luo, Z. Y., & Zhao, Y. (2016) · The Chemical Record · doi:10.1002/tcr.201600029 · Cited by 25
Wang, H., Zhao, W., Zhou, L., Wang, J., Liu, L., Wang, S., & Wang, Y. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b16396 · Cited by 25
Darwish, W. M., Abdoon, A. S. S., Shata, M., & ELMANSY, M. N. (2020) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2020.104575 · Cited by 26
Paulus, J., & Sewald, N. (2024) · Journal of Peptide Science · doi:10.1002/psc.3561 · Cited by 29
Immunostimulatory biomaterials to boost tumor immunogenicity
Shofolawe-Bakare, O. T., Stokes, L. D., Hossain, M., Smith, A. E., & Werfel, T. A. (2020) · Biomaterials Science · doi:10.1039/d0bm01183e · Cited by 24
Gorain, B., Karmakar, V., Sarkar, B., Dwivedi, M., Leong, J. T. L., Toh, J. H., Seah, E., Ling, K. Y., Chen, K. Y., Choudhury, H., et al. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.126623 · Cited by 27
In situ measurements of polymer micellization kinetics with millisecond temporal resolution
Kalkowski, J., Liu, C., Leon-Plata, P., Szymusiak, M., Zhang, P., Irving, T., Shang, W., Bilsel, O., & Liu, Y. (2019) · Macromolecules · doi:10.1021/acs.macromol.8b02257 · Cited by 23
Li, X., Xu, S., Su, Z., Shao, Z., & Huang, X. (2025) · ACS Omega · doi:10.1021/acsomega.4c10865 · Cited by 23
Bardajee, G. R., Mahmoodian, H., Shafiei, N., & Amiri, B. (2025) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5c00083 · Cited by 26
Polymeric Micelles for Pulmonary Drug Delivery: A Comprehensive Review
Teama, M. T., Abdelmalak, N. S., Naguib, M. J., & Ahmed, S. (2025) · BioNanoScience · doi:10.1007/s12668-025-02105-z · Cited by 23
“These investigations are also essential for verifying the efficient release of the medication under the influence of the triggering stimuli when micelles are made to deliver a specific target under particular environmental circumstances [186].”
Acid-triggered release of doxorubicin from a hydrazone-linked Gd 3+ -texaphyrin conjugate
Lee, M. H., Kim, E. J., Lee, H.-S., Park, S. Y., Hong, K. S., Kim, J. S., & Sessler, J. L. (2016) · Chemical Communications · doi:10.1039/c6cc05673c · Cited by 23
Shu, C., Sabi-mouka, E. M. B., Wang, X., & Li, D. (2017) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12732 · Cited by 23
Zhang, Y., Zhang, R., Illangakoon, U. E., Harker, A. H., Thrasivoulou, C., Parhizkar, M., Edirisinghe, M. J., & Luo, C. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s257353 · Cited by 23
Arslan, M., Bolu, B. S., Sanyal, R., & Sanyal, A. (2020) · Polymer Chemistry · doi:10.1039/d0py01049a · Cited by 23
DNA Walker‐Regulated Cancer Cell Growth Inhibition
Li, F., Cha, T., Pan, J., Özçelikkale, A., Han, B., & Choi, J. H. (2016) · ChemBioChem · doi:10.1002/cbic.201600052 · Cited by 23
Multifunctional Mitochondria-Targeting Nanosystems for Enhanced Anticancer Efficacy
Hu, T., Qin, Z., Shen, C., Gong, H., & He, Z. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.786621 · Cited by 24
“Although many mitochondria-targeting nanoparticles have been used to enhance cancer treatment, the leakage of drugs in cytoplasm and lysosome is challenging for all researchers when the therapeutic nanoparticles get inside the cancer cells (Wong and Choi, 2015; Xiong et al., 2016; Huang et al., 2021).”
BackgroundModified peroxamide-based reactive oxygen species (ROS)-responsive doxorubicin prodrugs
Jafari, M., Sriram, V., Premnauth, G., Merino, E. J., & Lee, J. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.105990 · Cited by 23
Gunasekaran, K., Vasamsetti, B. M. K., Thangavelu, P., Natesan, K., Mujyambere, B., Sundaram, V., Jayaraj, R., Kim, Y.-J., Samiappan, S., & Choi, J.-W. (2023) · Biomedicines · doi:10.3390/biomedicines11041021 · Cited by 22
Ma, J., Deng, H., Zhao, F., Deng, L., Wang, W., Dong, A., & Zhang, J. (2018) · Macromolecular Bioscience · doi:10.1002/mabi.201800049 · Cited by 23
Liu, H., Jiang, P., Li, Z., Li, X., Djaker, N., & Spadavecchia, J. (2018) · Particle & Particle Systems Characterization · doi:10.1002/ppsc.201800082 · Cited by 22
Cross‐Linked Surface Engineering to Improve Iron Porphyrin Catalytic Activity
Zhang, D., Liu, J., Du, P., Zhang, Z., Ning, X., Deng, Y. H., Yin, D., Chen, J., Han, Z., & Lu, X. (2020) · Small · doi:10.1002/smll.201905889 · Cited by 22
Activatable dual-functional molecular agents for imaging-guided cancer therapy
Zhang, P., Zhu, Y., Xiao, C., & Chen, X. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114725 · Cited by 21
Zhang, Q., Jin, C., Yu, J., & Lu, W. P. (2018) · ACS Omega · doi:10.1021/acsomega.8b01208 · Cited by 21
Xue, Y., Tian, J. H., Xu, L., Liu, Z., Shen, Y., & Zhang, W. (2018) · European Polymer Journal · doi:10.1016/j.eurpolymj.2018.11.033 · Cited by 21
Zhang, X., Zhao, Z., Yang, P., Liu, W., Fan, J., Zhang, B., & Yin, S. (2020) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2020.111054 · Cited by 21
Kühne, M., Lindemann, H., Grune, C., Schröder, D., Cseresnyés, Z., Godmann, M., Koschella, A., Figge, M. T., Eggeling, C., Fischer, D., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.10.006 · Cited by 21
Wróblewska, A. M., Milewska, A., Drozd, M., & Matczuk, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042324 · Cited by 21
“It is reported that covalent interactions between NPs and modifier molecules, achieved by the thiol group (–SH), ensure increased stability of nanoconjugates (especially in physiological conditions) [16,18,19] and can affect the cellular uptake [20].”
BackgroundIntelligence prediction of microfluidically prepared nanoparticles
Hanari, N., Mihandoost, S., & Rezvantalab, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-21471-y · Cited by 29
Guo, R. X., Zhang, Z., Shi, F., & Tang, P. (2016) · Organic Letters · doi:10.1021/acs.orglett.6b00130 · Cited by 20
Saini, B., Singh, R., Mukhopadhyay, S., & Mukherjee, T. K. (2021) · ACS Applied Nano Materials · doi:10.1021/acsanm.0c03356 · Cited by 20
Nath, R., Roy, R., Barai, G., Bairagi, S., Manna, S., & Chakraborty, R. (2021) · International Journal of Scientific Research in Science and Technology · doi:10.32628/ijsrst218422 · Cited by 21
Li, J., Rong, R.-X., Yang, Y. H., Hu, Z., Hu, B., Zhao, Y., Li, H., Hu, X., Wang, K., & Guo, D. (2023) · Materials Horizons · doi:10.1039/d3mh00018d · Cited by 20
Indurkhya, A., Patel, M., Sharma, P. A., Abed, S. N., Shnoudeh, A. J., Maheshwari, R., Deb, P. K., & Tekade, R. K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814423-7.00006-x · Cited by 38
Chemically Modified Variants of Fenofibrate with Antiglioblastoma Potential
Stalińska, J., Zimoląg, E., Pianovich, N., Zapata, A., Lassak, A., Rak, M., Dean, M. J., Uçar, D. A., Wyczechowska, D. D., Culicchia, F., et al. (2019) · Translational Oncology · doi:10.1016/j.tranon.2019.04.006 · Cited by 20
Multimeric Presentation of RGD Peptidomimetics Enhances Integrin Binding and Tumor Cell Uptake
Pina, A., Kadri, M., Arosio, D., Corso, A. D., Coll, J., Gennari, C., & Boturyn, D. (2020) · Chemistry - A European Journal · doi:10.1002/chem.202001115 · Cited by 22
Zhang, B., Yu, Q., & Liu, Y. (2020) · Chemistry - A European Journal · doi:10.1002/chem.202003328 · Cited by 20
Du, K., Xia, Q., Sun, J., & Feng, F. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c16962 · Cited by 23
Electrochemical Amination of Aryl Halides with NH 3
Liu, Y., Sun, Y., Deng, Y., & Qiu, Y. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202504459 · Cited by 19
Tailoring Therapy: Hydrogels as Tunable Platforms for Regenerative Medicine and Cancer Intervention
Munteanu, C., Prifti, E., Surd, A. O., & Mârza, S. M. (2025) · Gels · doi:10.3390/gels11090679 · Cited by 21
“The “pro-drug” technique is a sophisticated method that works exceptionally well with highly hydrophilic materials, such as polyethylene glycol (PEG) hydrogels [95].”
Catechin caged lanthanum orthovanadate nanorods for nuclear targeting and bioimaging applications
Tamilmani, V., Duraipandy, N., Syamala, K. M., Janardhanan, S. K., & Unni, N. B. (2016) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2016.11.111 · Cited by 19
Azizi, S., Nosrati, H., & Danafar, H. (2020) · Applied Organometallic Chemistry · doi:10.1002/aoc.5479 · Cited by 19
Cheng, Y., Dai, J., Sun, C., Liu, R., Zhai, T., Lou, X., & Xia, F. (2018) · Angewandte Chemie · doi:10.1002/ange.201712803 · Cited by 19
Guo, Y., Zhao, Y., Wang, T., Zhao, S., Qiu, H., Han, M., & Wang, X. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb02416e · Cited by 19
Chi, X., Yin, Z., Jin, J., Li, H., Zhou, J., Zhao, Z., Zhang, S., Zhao, W., Xie, C., Li, J., et al. (2017) · Nanotechnology · doi:10.1088/1361-6528/aa8791 · Cited by 19
A stimuli-responsive anticancer drug delivery system with inherent antibacterial activities
Dey, S., Patel, A., Raina, K., Pradhan, N., Biswas, O., Thummer, R. P., & Manna, D. (2020) · Chemical Communications · doi:10.1039/c9cc08834b · Cited by 19
Responsive nanomedicine strategies achieve pancreatic cancer precise theranostics
Li, F., Tang, Z., Zheng, Y., Jiang, T., Deng, L., Dai, W., Zhao, Y., Zheng, N., Liu, S., Fan, Y., et al. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.08.012 · Cited by 36
“Oxygen partial pressure progressively decreases from tumor periphery to core (minimum ≤ 10 mmHg), with extreme hypoxia zones showing 0.5 % of normal cellular oxygen levels (baseline 30 – 40 mmHg) [161,162].”
InfluentialNitrogen-Doped Carbon Nanotube Cups for Cancer Therapy
Burkert, S. C., He, X., Shurin, G. V., Nefedova, Y., Kagan, V. E., Shurin, M. R., & Star, A. (2021) · ACS Applied Nano Materials · doi:10.1021/acsanm.1c03245 · Cited by 18
Pina, A., Corso, A. D., Caruso, M., Belvisi, L., Arosio, D., Zanella, S., Gasparri, F., Albanese, C., Cucchi, U., Fraietta, I., et al. (2017) · ChemistrySelect · doi:10.1002/slct.201701052 · Cited by 25
Wang, W., Zhao, B.-Y., Meng, X., She, P., Zhang, P., Cao, Y., & Zhang, X. (2017) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2017.11.007 · Cited by 18
Pasban, S., Raissi, ., Pakdel, M., & Farzad, F. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118491 · Cited by 18
Tonk, C. H., Witzler, M., Schulze, M., & Tobiasch, E. (2020) · Learning materials in biosciences · doi:10.1007/978-3-030-33923-4_2 · Cited by 19
Pedroso‐Santana, S., Arcia, E. L., Fleitas‐Salazar, N., Gancino, M., Mansilla, R., Gómez-Gaete, C., Altamirano, C., Fernández, K. F., Ruiz, A., & Toledo, J. R. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111260 · Cited by 21
Nanotechnology for Therapeutics
Ghosal, A., Vashist, A., Tiwari, S., Sharmin, E., Ahmad, S., & Bhattacharya, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-63633-7_3 · Cited by 18
Recent advances in porous nanomaterials‐based drug delivery systems for osteoarthritis
Çïtoğlu, S., & Duran, H. (2023) · Nano Select · doi:10.1002/nano.202300099 · Cited by 17
Mechanistic basis of light induced cytotoxicity of photoactive nanomaterials
Choi, S. K. (2016) · NanoImpact · doi:10.1016/j.impact.2016.09.001 · Cited by 18
Self-citationIncorporating a Tetrapeptide into Lyotropic Direct Hexagonal Mesophase
Selivanova, N. M., Gubaidullin, A. T., & Galyametdinov, Y. G. (2020) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.0c00512 · Cited by 17
Linker Hydrophilicity Modulates the Anticancer Activity of RGD–Cryptophycin Conjugates
Anselmi, M., Borbély, A., Figueras, E., Michalek, C., Kemker, I., Gentilucci, L., & Sewald, N. (2020) · Chemistry - A European Journal · doi:10.1002/chem.202003471 · Cited by 19
Switchable Lipids: Conformational Change for Fast pH‐Triggered Cytoplasmic Delivery
Viricel, W., Mbarek, A., & Chain, J. L. (2015) · Angewandte Chemie · doi:10.1002/ange.201504661 · Cited by 18
Namasivayam, S. K. R., Srinivasan, S., Samrat, K., Priyalakshmi, B., Kumar, R. D., Bharani, R. S. A., Kumar, R. G., Kavisri, M., & Moovendhan, M. (2023) · Process Safety and Environmental Protection · doi:10.1016/j.psep.2023.01.050 · Cited by 17
Mesoscale simulations of diffusion and sedimentation in shape-anisotropic nanoparticle suspensions
Wani, Y. M., Kovakas, P. G., Nikoubashman, A., & Howard, M. P. (2024) · Soft Matter · doi:10.1039/d4sm00271g · Cited by 16
Nirmalananthan‐Budau, N., Rühle, B., Geißler, D., Moser, M., Kläber, C., Schäfer, A. H., & Resch‐Genger, U. (2019) · Scientific Reports · doi:10.1038/s41598-019-53773-3 · Cited by 17
Mukherjee, J., Wong, P. T., Tang, S., Gam, K., Coulter, A., Baker, J. R., & Choi, S. K. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00684 · Cited by 16
Self-citationMo, S., Wen, Y., Xue, F., Lan, H., Mao, Y., Lv, G., & Yi, T. (2016) · 中国科学通报:英文版 · doi:10.1007/s11434-016-1010-5 · Cited by 16
“carriers [37, 38].”
Metadata
- Authors
- Wong, P. T., & Choi, S. K.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Choi, Seok Ki
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-04-27
- Volume
- 115
- Issue
- 9
- Pages
- 3388-3432
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2053890812
- Cited by
- 507
- References
- 493
- Citations by year
- 2026: 28 · 2025: 35 · 2024: 31 · 2023: 45 · 2022: 35 · 2021: 51 · 2020: 59 · 2019: 64 · 2018: 60 · 2017: 48 · 2016: 40 · 2015: 11
- FWCI
- 3.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Chemical Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Office of the Vice President for Research, University of Michigan
- Shanghai Jiao Tong University
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- drug release mechanism, nanomedicine, controlled drug release, anticancer agents, nanocarriers
- MeSH terms
- Theranostic Nanomedicine, Animals, Drug Carriers, Humans, Drug Liberation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.